BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11244444)

  • 1. Epstein-Barr virus-related lymphoproliferative disease complicating childhood acute lymphoblastic leukemia: no recurrence after unrelated donor bone marrow transplantation.
    Pondarré C; Kebaili K; Dijoud F; Basset T; Philippe N; Bertrand Y
    Bone Marrow Transplant; 2001 Jan; 27(1):93-5. PubMed ID: 11244444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Successful donor lymphocyte infusion for Epstein-Barr virus-associated lymphoproliferative disorder after allogeneic bone marrow transplantation from an HLA 1-locus-mismatched sibling donor in a patient with acute lymphocytic leukemia].
    Yago K; Itoh M; Shimada H
    Rinsho Ketsueki; 2001 Nov; 42(11):1105-10. PubMed ID: 11808079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.
    Okamura T; Kishimoto T; Inoue M; Honda M; Yamashita N; Wakiguchi H; Yagita M; Hosoi G; Sako M; Yasui M; Yagi K; Kawa K
    Bone Marrow Transplant; 2003 Jan; 31(2):105-11. PubMed ID: 12621491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment with rituximab and donor lymphocyte infusions for fulminant EBV-associated lymphoproliferative disorder that developed 14 years after unrelated BMT.
    Kawaguchi T; Tsukamoto S; Ohwada C; Takeuchi M; Muto T; Tanaka S; Sakai S; Takeda Y; Abe D; Sakaida E; Shimizu N; Yokote K; Iseki T; Imadome KI; Nakaseko C
    Bone Marrow Transplant; 2011 Dec; 46(12):1583-5. PubMed ID: 21278799
    [No Abstract]   [Full Text] [Related]  

  • 5. Adoptive immunotherapy using donor leukocytes following bone marrow transplantation for chronic myeloid leukemia: is T cell dose important in determining biological response?
    Mackinnon S; Papadopoulos EB; Carabasi MH; Reich L; Collins NH; O'Reilly RJ
    Bone Marrow Transplant; 1995 Apr; 15(4):591-4. PubMed ID: 7655386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus-associated B cell lymphoproliferative disorder following mismatched related T cell-depleted bone marrow transplantation.
    Chiang KY; Hazlett LJ; Godder KT; Abhyankar SH; Christiansen NP; van Rhee F; Lee CG; Bridges K; Parrish RS; Henslee-Downey PJ
    Bone Marrow Transplant; 2001 Dec; 28(12):1117-23. PubMed ID: 11803352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor lymphocyte transfusion for the treatment of Epstein-Barr virus-associated lymphoproliferative disorder of the brain.
    Nagafuji K; Eto T; Hayashi S; Oshima K; Maeda Y; Gondo H; Inamura T; Niho Y
    Bone Marrow Transplant; 1998 Jun; 21(11):1155-8. PubMed ID: 9645581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Post-transplant EBV-associated lymphoproliferative disorders--report of two cases].
    Iwami H; Misawa A; Tsunamoto K; Kasubuchi Y; Naya M; Hojo M; Goto T; Hibi S; Matsumura T; Todo S; Imashuku S
    Rinsho Ketsueki; 1998 Mar; 39(3):198-204. PubMed ID: 9577643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unsuccessful CTL transfusion in a case of post-BMT Epstein-Barr virus-associated lymphoproliferative disorder (EBV-LPD).
    Imashuku S; Goto T; Matsumura T; Naya M; Yamori M; Hojo M; Hibi S; Todo S
    Bone Marrow Transplant; 1997 Aug; 20(4):337-40. PubMed ID: 9285550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants.
    Al-Kasim FA; Thornley I; Rolland M; Lau W; Tsang R; Freedman MH; Saunders EF; Calderwood S; Doyle JJ
    Br J Haematol; 2002 Feb; 116(2):483-90. PubMed ID: 11841456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients.
    Meijer E; Cornelissen JJ
    Curr Opin Hematol; 2008 Nov; 15(6):576-85. PubMed ID: 18832928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of rituximab and irradiated donor-derived lymphocytes to control Epstein-Barr virus-associated lymphoproliferation in patients undergoing related haplo-identical stem cell transplantation.
    McGuirk JP; Seropian S; Howe G; Smith B; Stoddart L; Cooper DL
    Bone Marrow Transplant; 1999 Dec; 24(11):1253-8. PubMed ID: 10642818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic active Epstein-Barr virus infection with mosquito allergy successfully treated with reduced-intensity unrelated allogeneic bone marrow transplantation in a boy.
    Matsunaga T; Kurosawa H; Okuya M; Nakajima D; Hagisawa S; Sato Y; Fukushima K; Sugita K; Arisaka O
    Pediatr Transplant; 2009 Mar; 13(2):231-4. PubMed ID: 18627511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining the origin of posttransplant lymphoproliferative disorder in a patient after a second allogeneic hematopoeitic stem cell transplantation for relapsed BCR-ABL positive acute lymphoblastic leukemia.
    Ruf S; Moser O; Wössmann W; Kreyenberg H; Wagner HJ
    J Pediatr Hematol Oncol; 2011 Jan; 33(1):50-4. PubMed ID: 21178708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disorder simultaneously affecting both B and T cells after allogeneic bone marrow transplantation.
    Chuhjo T; Yachie A; Kanegane H; Kimura H; Shiobara S; Nakao S
    Am J Hematol; 2003 Apr; 72(4):255-8. PubMed ID: 12666136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-cell treatment of Epstein--Barr-virus-associated lymphoproliferative disorders.
    Swinnen LJ
    Best Pract Res Clin Haematol; 2006; 19(4):839-47. PubMed ID: 16997187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-related lymphoproliferative disorders following bone marrow transplantation: an immunologic and genotypic analysis.
    Davey DD; Kamat D; Laszewski M; Goeken JA; Kemp JD; Trigg ME; Purtilo DT; Davis J; Dick FR
    Mod Pathol; 1989 Jan; 2(1):27-34. PubMed ID: 2537974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased incidence of EBV-associated lymphoproliferative disorders after allogeneic stem cell transplantation from matched unrelated donors due to a change of T cell depletion technique.
    Meijer E; Slaper-Cortenbach IC; Thijsen SF; Dekker AW; Verdonck LF
    Bone Marrow Transplant; 2002 Feb; 29(4):335-9. PubMed ID: 11896431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late onset Epstein-Barr virus-associated lymphoproliferative disease after allogeneic bone marrow transplant presenting as breast masses.
    Abhyankar SH; Chiang KY; McGuirk JP; Pati AR; Godder KT; Welsh JA; Waldron RL; McElveen JL; Henslee-Downey PJ
    Bone Marrow Transplant; 1998 Feb; 21(3):295-7. PubMed ID: 9489654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr-virus-related post-bone-marrow-transplant lymphoproliferative disease: association with cytomegalovirus infection and Down syndrome donor marrow.
    Patton DF; Wilkowski C; Hanson CA; Kersey JH; Bostrom B; McClain KL
    Am J Pediatr Hematol Oncol; 1989; 11(4):429-32. PubMed ID: 2559622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.